Journal of Emergencies, Trauma, and Shock
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
Users online:2210   Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size   

    Article Cited by others

ORIGINAL ARTICLE

Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience

Morel Nicolas, Chabarttier Cyrille, Merson Laurent, Lelias Agathe, Bernard Jean-Christophe, Delaunay François, Dabadie Philippe, Janvier Gérard

Year : 2012| Volume: 5| Issue : 2 | Page no: 143-148

   This article has been cited by
 
1 The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients
Mathijs R. Wirtz, Daisy V. Schalkers, J. Carel Goslings, Nicole P. Juffermans
Transfusion. 2020; 60(8): 1873
[Pubmed]  [Google Scholar] [DOI]
2 Massive posttraumatic bleeding: Epidemiology, causes, clinical features, and therapeutic management
Lippi, G. and Favaloro, E.J. and Cervellin, G.
Seminars in Thrombosis and Hemostasis. 2013; 39(1): 83-93
[Pubmed]  [Google Scholar]

 

Read this article